

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.71731025 |
| 2 | cellular ketone body metabolic process (GO:0046950) | 4.57977078 |
| 3 | ketone body metabolic process (GO:1902224) | 4.53558873 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.34733477 |
| 5 | regulation of hexokinase activity (GO:1903299) | 4.15004149 |
| 6 | regulation of glucokinase activity (GO:0033131) | 4.15004149 |
| 7 | respiratory chain complex IV assembly (GO:0008535) | 4.03156342 |
| 8 | protein complex biogenesis (GO:0070271) | 4.00487615 |
| 9 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.96398759 |
| 10 | purine nucleobase biosynthetic process (GO:0009113) | 3.96304076 |
| 11 | signal peptide processing (GO:0006465) | 3.92613353 |
| 12 | cytochrome complex assembly (GO:0017004) | 3.89481492 |
| 13 | DNA deamination (GO:0045006) | 3.79665632 |
| 14 | cellular response to interferon-beta (GO:0035458) | 3.75826235 |
| 15 | nucleobase biosynthetic process (GO:0046112) | 3.74578671 |
| 16 | protein K6-linked ubiquitination (GO:0085020) | 3.69400537 |
| 17 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.64180911 |
| 18 | cullin deneddylation (GO:0010388) | 3.62234684 |
| 19 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.61584305 |
| 20 | branched-chain amino acid catabolic process (GO:0009083) | 3.54952065 |
| 21 | electron transport chain (GO:0022900) | 3.49646961 |
| 22 | respiratory electron transport chain (GO:0022904) | 3.48160494 |
| 23 | protein deneddylation (GO:0000338) | 3.46404746 |
| 24 | piRNA metabolic process (GO:0034587) | 3.43328083 |
| 25 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.41230953 |
| 26 | serine family amino acid biosynthetic process (GO:0009070) | 3.38670528 |
| 27 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.37868502 |
| 28 | dopamine transport (GO:0015872) | 3.36720124 |
| 29 | CENP-A containing nucleosome assembly (GO:0034080) | 3.35307173 |
| 30 | DNA strand elongation (GO:0022616) | 3.32570665 |
| 31 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.29091780 |
| 32 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.29091780 |
| 33 | NADH dehydrogenase complex assembly (GO:0010257) | 3.29091780 |
| 34 | proteasome assembly (GO:0043248) | 3.27707599 |
| 35 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.26640203 |
| 36 | lactate metabolic process (GO:0006089) | 3.25834861 |
| 37 | mitotic metaphase plate congression (GO:0007080) | 3.24687457 |
| 38 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.22379956 |
| 39 | pseudouridine synthesis (GO:0001522) | 3.22158415 |
| 40 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.21045039 |
| 41 | inositol phosphate catabolic process (GO:0071545) | 3.20731253 |
| 42 | response to interferon-beta (GO:0035456) | 3.15202677 |
| 43 | amino acid salvage (GO:0043102) | 3.14483040 |
| 44 | L-methionine salvage (GO:0071267) | 3.14483040 |
| 45 | L-methionine biosynthetic process (GO:0071265) | 3.14483040 |
| 46 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.11630796 |
| 47 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.08511500 |
| 48 | inositol phosphate dephosphorylation (GO:0046855) | 3.08511500 |
| 49 | termination of RNA polymerase III transcription (GO:0006386) | 3.08351229 |
| 50 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.08351229 |
| 51 | oxidative phosphorylation (GO:0006119) | 3.08259007 |
| 52 | positive regulation of protein autophosphorylation (GO:0031954) | 3.07206454 |
| 53 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.07111439 |
| 54 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.06674523 |
| 55 | negative regulation of ligase activity (GO:0051352) | 3.06674523 |
| 56 | DNA unwinding involved in DNA replication (GO:0006268) | 3.05850534 |
| 57 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.05623116 |
| 58 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.05619167 |
| 59 | cysteine metabolic process (GO:0006534) | 3.05535973 |
| 60 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.04489908 |
| 61 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.03920342 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.03107006 |
| 63 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.03107006 |
| 64 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.02064968 |
| 65 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.01815050 |
| 66 | cytidine deamination (GO:0009972) | 3.01236101 |
| 67 | cytidine metabolic process (GO:0046087) | 3.01236101 |
| 68 | cytidine catabolic process (GO:0006216) | 3.01236101 |
| 69 | ribosome assembly (GO:0042255) | 3.01090126 |
| 70 | chromatin remodeling at centromere (GO:0031055) | 3.00723607 |
| 71 | AMP metabolic process (GO:0046033) | 3.00636854 |
| 72 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.99560958 |
| 73 | L-phenylalanine metabolic process (GO:0006558) | 2.99406313 |
| 74 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.99406313 |
| 75 | regulation of mitochondrial translation (GO:0070129) | 2.98839593 |
| 76 | L-phenylalanine catabolic process (GO:0006559) | 2.97728391 |
| 77 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.97728391 |
| 78 | urate metabolic process (GO:0046415) | 2.97154925 |
| 79 | maturation of 5.8S rRNA (GO:0000460) | 2.96536461 |
| 80 | regulation of cellular respiration (GO:0043457) | 2.95750098 |
| 81 | telomere maintenance via recombination (GO:0000722) | 2.95135787 |
| 82 | glycine metabolic process (GO:0006544) | 2.94773255 |
| 83 | ribosomal small subunit biogenesis (GO:0042274) | 2.93800171 |
| 84 | L-serine metabolic process (GO:0006563) | 2.93112021 |
| 85 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.93079428 |
| 86 | polyol catabolic process (GO:0046174) | 2.92701804 |
| 87 | transcription from mitochondrial promoter (GO:0006390) | 2.91710797 |
| 88 | rRNA methylation (GO:0031167) | 2.89805287 |
| 89 | nucleotide transmembrane transport (GO:1901679) | 2.89608569 |
| 90 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.88805735 |
| 91 | rRNA modification (GO:0000154) | 2.88589784 |
| 92 | formation of translation preinitiation complex (GO:0001731) | 2.87203353 |
| 93 | xenobiotic catabolic process (GO:0042178) | 2.86473084 |
| 94 | cholesterol biosynthetic process (GO:0006695) | 2.84800371 |
| 95 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84799294 |
| 96 | definitive hemopoiesis (GO:0060216) | 2.84663418 |
| 97 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.83893937 |
| 98 | viral transcription (GO:0019083) | 2.83839944 |
| 99 | branched-chain amino acid metabolic process (GO:0009081) | 2.80864774 |
| 100 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.78989604 |
| 101 | platelet dense granule organization (GO:0060155) | 2.78879604 |
| 102 | synapsis (GO:0007129) | 2.76922785 |
| 103 | translational termination (GO:0006415) | 2.76870595 |
| 104 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.76374725 |
| 105 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.76374725 |
| 106 | adenosine metabolic process (GO:0046085) | 2.75178054 |
| 107 | aldehyde catabolic process (GO:0046185) | 2.74508253 |
| 108 | mannosylation (GO:0097502) | 2.73480071 |
| 109 | keratinocyte development (GO:0003334) | 2.72842454 |
| 110 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72189588 |
| 111 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72189588 |
| 112 | folic acid metabolic process (GO:0046655) | 2.69733006 |
| 113 | serine family amino acid metabolic process (GO:0009069) | 2.69364248 |
| 114 | glucose 6-phosphate metabolic process (GO:0051156) | 2.69106440 |
| 115 | positive regulation of actin filament depolymerization (GO:0030836) | 2.67407986 |
| 116 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.66817186 |
| 117 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.66817186 |
| 118 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.66817186 |
| 119 | DNA replication initiation (GO:0006270) | 2.66146323 |
| 120 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.65296253 |
| 121 | maturation of SSU-rRNA (GO:0030490) | 2.64734387 |
| 122 | peptidyl-histidine modification (GO:0018202) | 2.64585352 |
| 123 | regulation of meiosis I (GO:0060631) | 2.63817665 |
| 124 | ATP synthesis coupled proton transport (GO:0015986) | 2.63603979 |
| 125 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.63603979 |
| 126 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.63240443 |
| 127 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.63240443 |
| 128 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.62920972 |
| 129 | glyoxylate metabolic process (GO:0046487) | 2.62889714 |
| 130 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.62778670 |
| 131 | methionine biosynthetic process (GO:0009086) | 2.61795325 |
| 132 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.60678009 |
| 133 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.60347887 |
| 134 | nucleoside salvage (GO:0043174) | 2.60154564 |
| 135 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.59248514 |
| 136 | mitochondrial RNA metabolic process (GO:0000959) | 2.58239179 |
| 137 | positive regulation of glycolytic process (GO:0045821) | 2.57888966 |
| 138 | aromatic amino acid family catabolic process (GO:0009074) | 2.57868564 |
| 139 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.56497158 |
| 140 | inner mitochondrial membrane organization (GO:0007007) | 2.56164471 |
| 141 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.56001885 |
| 142 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.56001885 |
| 143 | S-adenosylmethionine metabolic process (GO:0046500) | 2.55844959 |
| 144 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.54836770 |
| 145 | T cell apoptotic process (GO:0070231) | 2.54291421 |
| 146 | proton transport (GO:0015992) | 2.53461749 |
| 147 | hydrogen ion transmembrane transport (GO:1902600) | 2.53055363 |
| 148 | ribosome biogenesis (GO:0042254) | 2.52634937 |
| 149 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.52165533 |
| 150 | translational elongation (GO:0006414) | 2.51483450 |
| 151 | positive regulation of ligase activity (GO:0051351) | 2.51420309 |
| 152 | regulation of metalloenzyme activity (GO:0048552) | 2.51164378 |
| 153 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.50460199 |
| 154 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.50203981 |
| 155 | purine-containing compound salvage (GO:0043101) | 2.49819184 |
| 156 | mitotic recombination (GO:0006312) | 2.49373874 |
| 157 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.48637342 |
| 158 | hydrogen transport (GO:0006818) | 2.47746981 |
| 159 | sterol biosynthetic process (GO:0016126) | 2.47746618 |
| 160 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.47412262 |
| 161 | positive regulation of chromosome segregation (GO:0051984) | 2.46962401 |
| 162 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.46736800 |
| 163 | DNA replication-independent nucleosome organization (GO:0034724) | 2.46736800 |
| 164 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.46657837 |
| 165 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.46384221 |
| 166 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.44673967 |
| 167 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.43581197 |
| 168 | cell cycle G1/S phase transition (GO:0044843) | 2.43581197 |
| 169 | ribosomal large subunit biogenesis (GO:0042273) | 2.43453768 |
| 170 | aerobic respiration (GO:0009060) | 2.42829972 |
| 171 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.42397810 |
| 172 | sulfur amino acid biosynthetic process (GO:0000097) | 2.41995955 |
| 173 | cotranslational protein targeting to membrane (GO:0006613) | 2.41896849 |
| 174 | homocysteine metabolic process (GO:0050667) | 2.41722416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.76855473 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.54771707 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.07812881 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.64717397 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.58818775 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.55363271 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.54513514 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.05731516 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.05654303 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.79021830 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.55564163 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.55425635 |
| 13 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.55254694 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.52600753 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.50150093 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.44226139 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.43080558 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.42431052 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.29088922 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.27225429 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.15470814 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14209141 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12564255 |
| 24 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08714821 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.06614505 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.05183964 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 2.00321431 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.97643693 |
| 29 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.94373889 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.91204893 |
| 31 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.89049559 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.88961604 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.88353498 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.88229413 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.87369233 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.83961748 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.83152139 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.82860400 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81844575 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.79143644 |
| 41 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.78484787 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.78234249 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.76367174 |
| 44 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.74429085 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.74146301 |
| 46 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73669685 |
| 47 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.71974346 |
| 48 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71089776 |
| 49 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.70729532 |
| 50 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.68197151 |
| 51 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.67784198 |
| 52 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.67696923 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.67638136 |
| 54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.67139689 |
| 55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66772295 |
| 56 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66107663 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.65504704 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64295489 |
| 59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63735041 |
| 60 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62700614 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59628031 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.58333056 |
| 63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54880174 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.54426858 |
| 65 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.53445580 |
| 66 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.52229711 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.51018364 |
| 68 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50977863 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48323088 |
| 70 | MYC_22102868_ChIP-Seq_BL_Human | 1.47461509 |
| 71 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.46662772 |
| 72 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.44641827 |
| 73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43500396 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.42148264 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.41593719 |
| 76 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41580210 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41351123 |
| 78 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.39949539 |
| 79 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.39327689 |
| 80 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.36981294 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36857435 |
| 82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36655340 |
| 83 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.36584717 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.36541895 |
| 85 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36541895 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36527623 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36297902 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35123967 |
| 89 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.34691753 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34535057 |
| 91 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.33027383 |
| 92 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.32620396 |
| 93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32507242 |
| 94 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.30849242 |
| 95 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.30849242 |
| 96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.30595186 |
| 97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28524824 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27646836 |
| 99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26900183 |
| 100 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.25901185 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25739966 |
| 102 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25384513 |
| 103 | AR_20517297_ChIP-Seq_VCAP_Human | 1.25317003 |
| 104 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.23637376 |
| 105 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20737820 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20506047 |
| 107 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.19697788 |
| 108 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.19222827 |
| 109 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.18054829 |
| 110 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17885211 |
| 111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16929515 |
| 112 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.15033022 |
| 113 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14097113 |
| 114 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14097113 |
| 115 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10973813 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10884199 |
| 117 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09509665 |
| 118 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09354710 |
| 119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09347161 |
| 120 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09090163 |
| 121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08662642 |
| 122 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.07876375 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07307077 |
| 124 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06739279 |
| 125 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.06557842 |
| 126 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06551015 |
| 127 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06311976 |
| 128 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.05326006 |
| 129 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05278196 |
| 130 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05241416 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05237944 |
| 132 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05058852 |
| 133 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.04985087 |
| 134 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.04678615 |
| 135 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03877753 |
| 136 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03197095 |
| 137 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02960181 |
| 138 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02952016 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02681191 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02650804 |
| 141 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02298553 |
| 142 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02298138 |
| 143 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02212345 |
| 144 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01939202 |
| 145 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01856013 |
| 146 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00808542 |
| 147 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.99772584 |
| 148 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98955590 |
| 149 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98215262 |
| 150 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98158989 |
| 151 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98137827 |
| 152 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.97840378 |
| 153 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.96489791 |
| 154 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96006974 |
| 155 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95778392 |
| 156 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95402792 |
| 157 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95387599 |
| 158 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.95339636 |
| 159 | MYB_26560356_Chip-Seq_TH1_Human | 0.94905525 |
| 160 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.94769030 |
| 161 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.93864589 |
| 162 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.93696354 |
| 163 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93608236 |
| 164 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.92583390 |
| 165 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92331023 |
| 166 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91536125 |
| 167 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90403071 |
| 168 | MYB_26560356_Chip-Seq_TH2_Human | 0.90148024 |
| 169 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.89212433 |
| 170 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88269292 |
| 171 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.88162224 |
| 172 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87651283 |
| 173 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86656080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.79080169 |
| 2 | MP0000372_irregular_coat_pigmentation | 4.95306783 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.22905680 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.94814769 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.76545808 |
| 6 | MP0003950_abnormal_plasma_membrane | 3.40221872 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.39349816 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 3.28532383 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.95138036 |
| 10 | MP0009697_abnormal_copulation | 2.53860914 |
| 11 | MP0005365_abnormal_bile_salt | 2.53839297 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.53519385 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.46723451 |
| 14 | MP0003646_muscle_fatigue | 2.38423873 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.34200560 |
| 16 | MP0003693_abnormal_embryo_hatching | 2.31596197 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.26494212 |
| 18 | MP0004145_abnormal_muscle_electrophysio | 2.25557081 |
| 19 | MP0000749_muscle_degeneration | 2.25470821 |
| 20 | MP0005408_hypopigmentation | 2.25004910 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 2.21093611 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.20282977 |
| 23 | MP0004147_increased_porphyrin_level | 2.18419255 |
| 24 | MP0005379_endocrine/exocrine_gland_phen | 2.18187688 |
| 25 | MP0010386_abnormal_urinary_bladder | 1.97144725 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.91197021 |
| 27 | MP0008058_abnormal_DNA_repair | 1.90535872 |
| 28 | MP0005645_abnormal_hypothalamus_physiol | 1.88175895 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.87350253 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.86220919 |
| 31 | MP0002163_abnormal_gland_morphology | 1.85850828 |
| 32 | MP0005332_abnormal_amino_acid | 1.83789283 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.78055318 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.76660014 |
| 35 | MP0009840_abnormal_foam_cell | 1.74008002 |
| 36 | MP0002102_abnormal_ear_morphology | 1.72509699 |
| 37 | MP0006054_spinal_hemorrhage | 1.69826304 |
| 38 | MP0005171_absent_coat_pigmentation | 1.68656691 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.63766490 |
| 40 | MP0003786_premature_aging | 1.62773815 |
| 41 | MP0003077_abnormal_cell_cycle | 1.62664355 |
| 42 | MP0003718_maternal_effect | 1.61240302 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.60623205 |
| 44 | MP0002398_abnormal_bone_marrow | 1.60361450 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59597380 |
| 46 | MP0001529_abnormal_vocalization | 1.57903479 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.57799816 |
| 48 | MP0005671_abnormal_response_to | 1.57759436 |
| 49 | MP0000015_abnormal_ear_pigmentation | 1.56335473 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.56231391 |
| 51 | MP0010094_abnormal_chromosome_stability | 1.56017879 |
| 52 | MP0002160_abnormal_reproductive_system | 1.55939288 |
| 53 | MP0000427_abnormal_hair_cycle | 1.54578394 |
| 54 | MP0006082_CNS_inflammation | 1.53743406 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.52162272 |
| 56 | MP0005451_abnormal_body_composition | 1.51953306 |
| 57 | MP0008877_abnormal_DNA_methylation | 1.49265946 |
| 58 | MP0001800_abnormal_humoral_immune | 1.49243335 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.48099213 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.46869357 |
| 61 | MP0005025_abnormal_response_to | 1.46846790 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.44941347 |
| 63 | MP0003186_abnormal_redox_activity | 1.43497144 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.43097268 |
| 65 | MP0006035_abnormal_mitochondrial_morpho | 1.42405706 |
| 66 | MP0002938_white_spotting | 1.40176507 |
| 67 | MP0001348_abnormal_lacrimal_gland | 1.40163710 |
| 68 | MP0002722_abnormal_immune_system | 1.39718827 |
| 69 | MP0008007_abnormal_cellular_replicative | 1.37839274 |
| 70 | MP0009379_abnormal_foot_pigmentation | 1.37700317 |
| 71 | MP0008872_abnormal_physiological_respon | 1.37688514 |
| 72 | MP0001905_abnormal_dopamine_level | 1.37304513 |
| 73 | MP0005389_reproductive_system_phenotype | 1.35899463 |
| 74 | MP0000716_abnormal_immune_system | 1.35431768 |
| 75 | MP0001661_extended_life_span | 1.34507616 |
| 76 | MP0008469_abnormal_protein_level | 1.33131935 |
| 77 | MP0002429_abnormal_blood_cell | 1.32568442 |
| 78 | MP0010329_abnormal_lipoprotein_level | 1.32234720 |
| 79 | MP0000490_abnormal_crypts_of | 1.31615283 |
| 80 | MP0002452_abnormal_antigen_presenting | 1.29477798 |
| 81 | MP0001853_heart_inflammation | 1.29394676 |
| 82 | MP0002723_abnormal_immune_serum | 1.27742360 |
| 83 | MP0004036_abnormal_muscle_relaxation | 1.27352629 |
| 84 | MP0005253_abnormal_eye_physiology | 1.26736689 |
| 85 | MP0002420_abnormal_adaptive_immunity | 1.26594731 |
| 86 | MP0009785_altered_susceptibility_to | 1.26172380 |
| 87 | MP0002693_abnormal_pancreas_physiology | 1.25923176 |
| 88 | MP0001819_abnormal_immune_cell | 1.25274988 |
| 89 | MP0003763_abnormal_thymus_physiology | 1.23964605 |
| 90 | MP0000538_abnormal_urinary_bladder | 1.22643632 |
| 91 | MP0001944_abnormal_pancreas_morphology | 1.22257604 |
| 92 | MP0002090_abnormal_vision | 1.19824678 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 1.19377264 |
| 94 | MP0001764_abnormal_homeostasis | 1.19282340 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 1.19090550 |
| 96 | MP0000516_abnormal_urinary_system | 1.19090550 |
| 97 | MP0000685_abnormal_immune_system | 1.17705778 |
| 98 | MP0003011_delayed_dark_adaptation | 1.17531819 |
| 99 | MP0005310_abnormal_salivary_gland | 1.17409058 |
| 100 | MP0000609_abnormal_liver_physiology | 1.15589201 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 1.15572074 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 1.14611616 |
| 103 | MP0010155_abnormal_intestine_physiology | 1.13346821 |
| 104 | MP0004215_abnormal_myocardial_fiber | 1.13112703 |
| 105 | MP0003866_abnormal_defecation | 1.12620267 |
| 106 | MP0002928_abnormal_bile_duct | 1.12604339 |
| 107 | MP0004510_myositis | 1.12515991 |
| 108 | MP0005058_abnormal_lysosome_morphology | 1.11242131 |
| 109 | MP0000598_abnormal_liver_morphology | 1.10069377 |
| 110 | MP0004084_abnormal_cardiac_muscle | 1.10059497 |
| 111 | MP0003436_decreased_susceptibility_to | 1.09652019 |
| 112 | MP0008057_abnormal_DNA_replication | 1.08534211 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 1.08392787 |
| 114 | MP0002166_altered_tumor_susceptibility | 1.08273282 |
| 115 | MP0002419_abnormal_innate_immunity | 1.07054268 |
| 116 | MP0009643_abnormal_urine_homeostasis | 1.06356669 |
| 117 | MP0004043_abnormal_pH_regulation | 1.05713614 |
| 118 | MP0005646_abnormal_pituitary_gland | 1.05451710 |
| 119 | MP0002909_abnormal_adrenal_gland | 1.05208105 |
| 120 | MP0005387_immune_system_phenotype | 1.04557864 |
| 121 | MP0001790_abnormal_immune_system | 1.04557864 |
| 122 | MP0009764_decreased_sensitivity_to | 1.03717424 |
| 123 | MP0002269_muscular_atrophy | 1.03145892 |
| 124 | MP0005266_abnormal_metabolism | 1.02571434 |
| 125 | MP0001845_abnormal_inflammatory_respons | 1.02010371 |
| 126 | MP0001873_stomach_inflammation | 0.99096197 |
| 127 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98731145 |
| 128 | MP0000703_abnormal_thymus_morphology | 0.98519682 |
| 129 | MP0003111_abnormal_nucleus_morphology | 0.97232324 |
| 130 | MP0002132_abnormal_respiratory_system | 0.97209751 |
| 131 | MP0002234_abnormal_pharynx_morphology | 0.97108772 |
| 132 | MP0003195_calcinosis | 0.97036602 |
| 133 | MP0003252_abnormal_bile_duct | 0.97017606 |
| 134 | MP0000613_abnormal_salivary_gland | 0.96839932 |
| 135 | MP0000003_abnormal_adipose_tissue | 0.96666194 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.96294061 |
| 137 | MP0008873_increased_physiological_sensi | 0.95881532 |
| 138 | MP0008775_abnormal_heart_ventricle | 0.95036672 |
| 139 | MP0005084_abnormal_gallbladder_morpholo | 0.94781484 |
| 140 | MP0005220_abnormal_exocrine_pancreas | 0.94409222 |
| 141 | MP0005636_abnormal_mineral_homeostasis | 0.93382581 |
| 142 | MP0005330_cardiomyopathy | 0.93115051 |
| 143 | MP0009046_muscle_twitch | 0.93025151 |
| 144 | MP0002254_reproductive_system_inflammat | 0.91817828 |
| 145 | MP0001542_abnormal_bone_strength | 0.91249453 |
| 146 | MP0004142_abnormal_muscle_tone | 0.91014482 |
| 147 | MP0000358_abnormal_cell_content/ | 0.89549482 |
| 148 | MP0005410_abnormal_fertilization | 0.87423995 |
| 149 | MP0004019_abnormal_vitamin_homeostasis | 0.86542616 |
| 150 | MP0003315_abnormal_perineum_morphology | 0.85386021 |
| 151 | MP0002019_abnormal_tumor_incidence | 0.84254070 |
| 152 | MP0001756_abnormal_urination | 0.82917250 |
| 153 | MP0002136_abnormal_kidney_physiology | 0.82856107 |
| 154 | MP0001986_abnormal_taste_sensitivity | 0.81426304 |
| 155 | MP0003045_fibrosis | 0.81365144 |
| 156 | MP0005395_other_phenotype | 0.80153065 |
| 157 | MP0002006_tumorigenesis | 0.79710297 |
| 158 | MP0002295_abnormal_pulmonary_circulatio | 0.79600565 |
| 159 | MP0002332_abnormal_exercise_endurance | 0.79469453 |
| 160 | MP0002736_abnormal_nociception_after | 0.79211806 |
| 161 | MP0000371_diluted_coat_color | 0.78682196 |
| 162 | MP0002405_respiratory_system_inflammati | 0.78034826 |
| 163 | MP0008932_abnormal_embryonic_tissue | 0.77104017 |
| 164 | MP0004947_skin_inflammation | 0.76986869 |
| 165 | MP0002078_abnormal_glucose_homeostasis | 0.76950579 |
| 166 | MP0002095_abnormal_skin_pigmentation | 0.76081496 |
| 167 | MP0005083_abnormal_biliary_tract | 0.74907794 |
| 168 | MP0001730_embryonic_growth_arrest | 0.74779601 |
| 169 | MP0005620_abnormal_muscle_contractility | 0.74748698 |
| 170 | MP0002638_abnormal_pupillary_reflex | 0.74185736 |
| 171 | MP0001919_abnormal_reproductive_system | 0.71515098 |
| 172 | MP0010678_abnormal_skin_adnexa | 0.68823274 |
| 173 | MP0002106_abnormal_muscle_physiology | 0.67044571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 5.06003393 |
| 2 | Nemaline bodies (HP:0003798) | 3.98024656 |
| 3 | Progressive macrocephaly (HP:0004481) | 3.93192235 |
| 4 | 3-Methylglutaconic aciduria (HP:0003535) | 3.79394023 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65517658 |
| 6 | Muscle fiber inclusion bodies (HP:0100299) | 3.49724781 |
| 7 | Ketoacidosis (HP:0001993) | 3.49192970 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.48837685 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.48807684 |
| 10 | Petechiae (HP:0000967) | 3.38350772 |
| 11 | Abnormality of T cell physiology (HP:0011840) | 3.33210785 |
| 12 | Increased serum pyruvate (HP:0003542) | 3.29458801 |
| 13 | Abnormality of glycolysis (HP:0004366) | 3.29458801 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 3.23251192 |
| 15 | Thrombocytosis (HP:0001894) | 3.17717092 |
| 16 | Lipid accumulation in hepatocytes (HP:0006561) | 3.17655753 |
| 17 | Chronic otitis media (HP:0000389) | 3.12078596 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.05123917 |
| 19 | Hepatocellular necrosis (HP:0001404) | 3.04092894 |
| 20 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.03944568 |
| 21 | Hypoplasia of the fovea (HP:0007750) | 3.03944568 |
| 22 | Hepatic necrosis (HP:0002605) | 3.02982233 |
| 23 | Hypothermia (HP:0002045) | 3.02867276 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.01560196 |
| 25 | Large for gestational age (HP:0001520) | 3.00034908 |
| 26 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.96820440 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 2.95632389 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 2.93371766 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.93323904 |
| 30 | Purpura (HP:0000979) | 2.90185053 |
| 31 | Type 2 muscle fiber atrophy (HP:0003554) | 2.85146389 |
| 32 | Recurrent viral infections (HP:0004429) | 2.85141283 |
| 33 | Proximal tubulopathy (HP:0000114) | 2.81924787 |
| 34 | Hyperammonemia (HP:0001987) | 2.80417942 |
| 35 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.78931920 |
| 36 | Megaloblastic anemia (HP:0001889) | 2.76697602 |
| 37 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.74256149 |
| 38 | Glycosuria (HP:0003076) | 2.71480761 |
| 39 | Abnormality of urine glucose concentration (HP:0011016) | 2.71480761 |
| 40 | Albinism (HP:0001022) | 2.67849338 |
| 41 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.65966122 |
| 42 | Acute encephalopathy (HP:0006846) | 2.64546325 |
| 43 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.64208254 |
| 44 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.64208254 |
| 45 | Mitochondrial inheritance (HP:0001427) | 2.63175185 |
| 46 | Pancreatic cysts (HP:0001737) | 2.63097707 |
| 47 | Abnormality of the renal cortex (HP:0011035) | 2.63044750 |
| 48 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.61647196 |
| 49 | Intrahepatic cholestasis (HP:0001406) | 2.61575456 |
| 50 | Conjunctival hamartoma (HP:0100780) | 2.60798487 |
| 51 | Abnormality of the fovea (HP:0000493) | 2.60427194 |
| 52 | Delayed gross motor development (HP:0002194) | 2.59427287 |
| 53 | Exertional dyspnea (HP:0002875) | 2.59342940 |
| 54 | Increased CSF lactate (HP:0002490) | 2.56063724 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.55160374 |
| 56 | Increased intramyocellular lipid droplets (HP:0012240) | 2.55140603 |
| 57 | Congenital stationary night blindness (HP:0007642) | 2.53716347 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 2.52991417 |
| 59 | Generalized aminoaciduria (HP:0002909) | 2.52112097 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.49702676 |
| 61 | Impaired platelet aggregation (HP:0003540) | 2.48700384 |
| 62 | Abnormal platelet function (HP:0011869) | 2.48700384 |
| 63 | Type I transferrin isoform profile (HP:0003642) | 2.45027901 |
| 64 | Respiratory failure (HP:0002878) | 2.45006681 |
| 65 | Cholecystitis (HP:0001082) | 2.44272408 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.44272408 |
| 67 | Renal cortical cysts (HP:0000803) | 2.43671709 |
| 68 | Acute necrotizing encephalopathy (HP:0006965) | 2.42945309 |
| 69 | Increased serum lactate (HP:0002151) | 2.42418894 |
| 70 | Hyperglycemia (HP:0003074) | 2.41109442 |
| 71 | Abnormality of placental membranes (HP:0011409) | 2.38198412 |
| 72 | Amniotic constriction ring (HP:0009775) | 2.38198412 |
| 73 | Deep venous thrombosis (HP:0002625) | 2.37745493 |
| 74 | Lactic acidosis (HP:0003128) | 2.35609271 |
| 75 | Calf muscle hypertrophy (HP:0008981) | 2.35318993 |
| 76 | Cutaneous melanoma (HP:0012056) | 2.34682949 |
| 77 | Xanthomatosis (HP:0000991) | 2.34662717 |
| 78 | Increased muscle lipid content (HP:0009058) | 2.33169706 |
| 79 | Gingival bleeding (HP:0000225) | 2.32851890 |
| 80 | Abnormality of T cells (HP:0002843) | 2.32815202 |
| 81 | Ketosis (HP:0001946) | 2.32404211 |
| 82 | Hypokinesia (HP:0002375) | 2.32217995 |
| 83 | Cerebral edema (HP:0002181) | 2.31776714 |
| 84 | Molar tooth sign on MRI (HP:0002419) | 2.30963021 |
| 85 | Abnormality of midbrain morphology (HP:0002418) | 2.30963021 |
| 86 | Methylmalonic acidemia (HP:0002912) | 2.30781074 |
| 87 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.29405588 |
| 88 | Hypolipoproteinemia (HP:0010981) | 2.29321380 |
| 89 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.28865610 |
| 90 | Abnormal platelet volume (HP:0011876) | 2.28594315 |
| 91 | Macrocytic anemia (HP:0001972) | 2.28140298 |
| 92 | Conjugated hyperbilirubinemia (HP:0002908) | 2.27479527 |
| 93 | Popliteal pterygium (HP:0009756) | 2.24811578 |
| 94 | Hamartoma of the eye (HP:0010568) | 2.24763774 |
| 95 | Hyperbilirubinemia (HP:0002904) | 2.24513563 |
| 96 | IgM deficiency (HP:0002850) | 2.23964836 |
| 97 | Abnormality of serum amino acid levels (HP:0003112) | 2.23245386 |
| 98 | Prolonged partial thromboplastin time (HP:0003645) | 2.21852653 |
| 99 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.21532188 |
| 100 | Tongue fasciculations (HP:0001308) | 2.19874751 |
| 101 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19721724 |
| 102 | Joint hemorrhage (HP:0005261) | 2.19000036 |
| 103 | Birth length less than 3rd percentile (HP:0003561) | 2.17447831 |
| 104 | Fat malabsorption (HP:0002630) | 2.16483461 |
| 105 | Increased mean platelet volume (HP:0011877) | 2.15930671 |
| 106 | Muscle fiber atrophy (HP:0100295) | 2.15793973 |
| 107 | Abnormality of T cell number (HP:0011839) | 2.14663937 |
| 108 | Hyperphosphaturia (HP:0003109) | 2.13752509 |
| 109 | Severe visual impairment (HP:0001141) | 2.12968189 |
| 110 | Recurrent cutaneous fungal infections (HP:0011370) | 2.12804716 |
| 111 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.12804716 |
| 112 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12606598 |
| 113 | Abnormal protein glycosylation (HP:0012346) | 2.12606598 |
| 114 | Abnormal glycosylation (HP:0012345) | 2.12606598 |
| 115 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12606598 |
| 116 | Lethargy (HP:0001254) | 2.12260066 |
| 117 | Exercise intolerance (HP:0003546) | 2.12184075 |
| 118 | Reticulocytopenia (HP:0001896) | 2.12118442 |
| 119 | Recurrent skin infections (HP:0001581) | 2.10393033 |
| 120 | Optic disc pallor (HP:0000543) | 2.10311417 |
| 121 | Cerebral hypomyelination (HP:0006808) | 2.09708454 |
| 122 | IgG deficiency (HP:0004315) | 2.08003367 |
| 123 | Pancreatic fibrosis (HP:0100732) | 2.07367916 |
| 124 | Hyperglycinuria (HP:0003108) | 2.06278193 |
| 125 | Prolonged bleeding time (HP:0003010) | 2.06168607 |
| 126 | Respiratory difficulties (HP:0002880) | 2.06166620 |
| 127 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.05089311 |
| 128 | Abnormality of glycine metabolism (HP:0010895) | 2.05089311 |
| 129 | Diminished movement (HP:0002374) | 2.04449516 |
| 130 | Methylmalonic aciduria (HP:0012120) | 2.03455827 |
| 131 | Hyperglycinemia (HP:0002154) | 2.02101650 |
| 132 | Abnormality of purine metabolism (HP:0004352) | 2.02002399 |
| 133 | Pustule (HP:0200039) | 2.01943794 |
| 134 | Abnormal number of erythroid precursors (HP:0012131) | 2.01276484 |
| 135 | Nephronophthisis (HP:0000090) | 2.00495727 |
| 136 | Recurrent fungal infections (HP:0002841) | 2.00035579 |
| 137 | Weak cry (HP:0001612) | 1.99417975 |
| 138 | Neck muscle weakness (HP:0000467) | 1.98884069 |
| 139 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.98668683 |
| 140 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.98651211 |
| 141 | Palpitations (HP:0001962) | 1.98497372 |
| 142 | CNS demyelination (HP:0007305) | 1.97705506 |
| 143 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.97186777 |
| 144 | Ileus (HP:0002595) | 1.96790163 |
| 145 | Hyperlipoproteinemia (HP:0010980) | 1.96689476 |
| 146 | Menorrhagia (HP:0000132) | 1.95652674 |
| 147 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.95384327 |
| 148 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.93554239 |
| 149 | Neoplasm of the adrenal gland (HP:0100631) | 1.91819477 |
| 150 | Spastic paraparesis (HP:0002313) | 1.90973407 |
| 151 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.90848151 |
| 152 | Type II lissencephaly (HP:0007260) | 1.90396064 |
| 153 | Delayed epiphyseal ossification (HP:0002663) | 1.89840293 |
| 154 | T lymphocytopenia (HP:0005403) | 1.89003442 |
| 155 | True hermaphroditism (HP:0010459) | 1.87661703 |
| 156 | Bone cyst (HP:0012062) | 1.87287918 |
| 157 | Aplastic anemia (HP:0001915) | 1.87217179 |
| 158 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.86562455 |
| 159 | Abnormality of vitamin B metabolism (HP:0004340) | 1.84173191 |
| 160 | Furrowed tongue (HP:0000221) | 1.83610973 |
| 161 | Abnormality of the neuromuscular junction (HP:0003398) | 1.82065192 |
| 162 | Fatigable weakness (HP:0003473) | 1.82065192 |
| 163 | Vascular calcification (HP:0004934) | 1.81633480 |
| 164 | Hypoalbuminemia (HP:0003073) | 1.81584592 |
| 165 | Abnormal albumin level (HP:0012116) | 1.81584592 |
| 166 | Fibular aplasia (HP:0002990) | 1.80389068 |
| 167 | Abnormality of proline metabolism (HP:0010907) | 1.79429220 |
| 168 | Hydroxyprolinuria (HP:0003080) | 1.79429220 |
| 169 | Abnormality of the renal medulla (HP:0100957) | 1.79302250 |
| 170 | Neuroendocrine neoplasm (HP:0100634) | 1.78539322 |
| 171 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.78371136 |
| 172 | Exercise-induced muscle cramps (HP:0003710) | 1.78080048 |
| 173 | Azoospermia (HP:0000027) | 1.78054316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 5.18890581 |
| 2 | BUB1 | 4.06311183 |
| 3 | WEE1 | 3.25161834 |
| 4 | NME2 | 3.10403509 |
| 5 | MUSK | 2.95022347 |
| 6 | BRSK2 | 2.72300448 |
| 7 | MAP4K1 | 2.70685145 |
| 8 | STK16 | 2.58105836 |
| 9 | MAP3K12 | 2.53657936 |
| 10 | NUAK1 | 2.43545777 |
| 11 | VRK2 | 2.40260789 |
| 12 | PHKG2 | 2.40240091 |
| 13 | PHKG1 | 2.40240091 |
| 14 | MST4 | 2.30329700 |
| 15 | MKNK1 | 2.26206849 |
| 16 | BMPR1B | 2.11162511 |
| 17 | BCKDK | 2.04707273 |
| 18 | CDC7 | 2.04322889 |
| 19 | OBSCN | 1.98088020 |
| 20 | ACVR1B | 1.94126370 |
| 21 | TESK2 | 1.84313420 |
| 22 | BLK | 1.83791634 |
| 23 | PIM2 | 1.70765269 |
| 24 | STK10 | 1.70027959 |
| 25 | ARAF | 1.69876366 |
| 26 | GRK1 | 1.69744747 |
| 27 | PBK | 1.65046778 |
| 28 | MAPKAPK3 | 1.64030530 |
| 29 | PLK2 | 1.63333798 |
| 30 | TRIM28 | 1.62222075 |
| 31 | GRK6 | 1.61315803 |
| 32 | PLK4 | 1.57237748 |
| 33 | MYLK | 1.57086646 |
| 34 | CDK19 | 1.56913094 |
| 35 | MAP4K2 | 1.55163164 |
| 36 | SIK3 | 1.54862530 |
| 37 | KIT | 1.52308913 |
| 38 | RPS6KB2 | 1.45496776 |
| 39 | ERBB3 | 1.36895173 |
| 40 | PLK3 | 1.36556501 |
| 41 | PINK1 | 1.36472030 |
| 42 | PNCK | 1.36341009 |
| 43 | ZAK | 1.35445311 |
| 44 | SYK | 1.34744681 |
| 45 | MAP3K6 | 1.33042392 |
| 46 | TXK | 1.31281167 |
| 47 | BCR | 1.30868316 |
| 48 | TRPM7 | 1.29287973 |
| 49 | BTK | 1.28402048 |
| 50 | ZAP70 | 1.28300321 |
| 51 | FGFR2 | 1.26127972 |
| 52 | FLT3 | 1.23696904 |
| 53 | EIF2AK3 | 1.21159492 |
| 54 | EPHB1 | 1.20381878 |
| 55 | STK39 | 1.19590518 |
| 56 | PASK | 1.17897429 |
| 57 | TSSK6 | 1.15368024 |
| 58 | MAP3K8 | 1.12760390 |
| 59 | LRRK2 | 1.10924480 |
| 60 | WNK4 | 1.08570687 |
| 61 | TEC | 1.07079642 |
| 62 | CCNB1 | 1.06327452 |
| 63 | TGFBR1 | 1.05198889 |
| 64 | OXSR1 | 1.02384718 |
| 65 | BRSK1 | 1.01315571 |
| 66 | TYK2 | 1.00490115 |
| 67 | TLK1 | 1.00467434 |
| 68 | PIK3CG | 1.00137747 |
| 69 | PTK2B | 0.99380759 |
| 70 | EEF2K | 0.99225346 |
| 71 | CDK7 | 0.98453254 |
| 72 | INSRR | 0.97754044 |
| 73 | CSNK1G3 | 0.97682118 |
| 74 | MAP2K3 | 0.93037988 |
| 75 | FER | 0.91384159 |
| 76 | PLK1 | 0.89355354 |
| 77 | PAK3 | 0.88294007 |
| 78 | PDK2 | 0.88217849 |
| 79 | TAF1 | 0.84291448 |
| 80 | EIF2AK2 | 0.83529256 |
| 81 | ADRBK1 | 0.80442614 |
| 82 | STK3 | 0.79616992 |
| 83 | STK24 | 0.78527286 |
| 84 | NME1 | 0.77646578 |
| 85 | PRKCE | 0.76851919 |
| 86 | JAK3 | 0.76731652 |
| 87 | CSNK1A1L | 0.76439846 |
| 88 | TNIK | 0.75874677 |
| 89 | MATK | 0.74968807 |
| 90 | WNK3 | 0.74457509 |
| 91 | RPS6KA4 | 0.73099890 |
| 92 | AURKA | 0.72539723 |
| 93 | BMPR2 | 0.72024301 |
| 94 | CSF1R | 0.71301538 |
| 95 | BRAF | 0.70939844 |
| 96 | CSNK1G1 | 0.70922858 |
| 97 | NEK2 | 0.69901369 |
| 98 | VRK1 | 0.69870827 |
| 99 | STK38L | 0.68531240 |
| 100 | PRKCI | 0.66756017 |
| 101 | ERN1 | 0.66380532 |
| 102 | LCK | 0.63974828 |
| 103 | LYN | 0.62288134 |
| 104 | TAOK3 | 0.61975386 |
| 105 | CASK | 0.61597919 |
| 106 | MST1R | 0.61536899 |
| 107 | SRPK1 | 0.61058166 |
| 108 | ERBB4 | 0.58371705 |
| 109 | CDK8 | 0.58244739 |
| 110 | PIM1 | 0.57749786 |
| 111 | NEK1 | 0.56892817 |
| 112 | AURKB | 0.56185205 |
| 113 | DAPK1 | 0.56075727 |
| 114 | MAP2K6 | 0.55439134 |
| 115 | ILK | 0.55037851 |
| 116 | STK4 | 0.52897722 |
| 117 | MAPKAPK5 | 0.51355571 |
| 118 | IKBKB | 0.51139549 |
| 119 | GRK5 | 0.50836588 |
| 120 | ATR | 0.50262460 |
| 121 | FRK | 0.49804032 |
| 122 | MAPK4 | 0.48600266 |
| 123 | FGFR4 | 0.48253817 |
| 124 | MKNK2 | 0.48230812 |
| 125 | CAMK2D | 0.47810036 |
| 126 | ADRBK2 | 0.47062683 |
| 127 | CSNK2A2 | 0.46479358 |
| 128 | MAP3K10 | 0.45939286 |
| 129 | MAPK11 | 0.45405496 |
| 130 | GRK7 | 0.43577397 |
| 131 | ABL2 | 0.43496638 |
| 132 | TTK | 0.42393625 |
| 133 | TBK1 | 0.42392058 |
| 134 | CSNK2A1 | 0.41942568 |
| 135 | MAP3K11 | 0.41650090 |
| 136 | NLK | 0.41301460 |
| 137 | IKBKE | 0.40861049 |
| 138 | CDK4 | 0.38099044 |
| 139 | ITK | 0.37723618 |
| 140 | LIMK1 | 0.37593630 |
| 141 | MET | 0.36004683 |
| 142 | PRKCD | 0.35813033 |
| 143 | RIPK4 | 0.35748810 |
| 144 | PRKAA2 | 0.34884009 |
| 145 | PKN2 | 0.34852770 |
| 146 | CAMKK2 | 0.34404320 |
| 147 | CSNK1G2 | 0.34334108 |
| 148 | PIK3CA | 0.33588170 |
| 149 | MOS | 0.32980000 |
| 150 | SCYL2 | 0.31792102 |
| 151 | PAK1 | 0.31108671 |
| 152 | ROCK1 | 0.30007094 |
| 153 | PRKCG | 0.29784977 |
| 154 | AKT3 | 0.28162128 |
| 155 | IGF1R | 0.27602961 |
| 156 | AKT2 | 0.26860099 |
| 157 | CSNK1A1 | 0.26619971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.56381594 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.17109203 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.65182179 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.60494100 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.50413587 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.46414653 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.24642193 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.18293157 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.05235060 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 1.89799781 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.88662056 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.81277781 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.76733564 |
| 14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.75665561 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.75373457 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74642822 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73353235 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.72698949 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.71111008 |
| 20 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.69431616 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.65500893 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63736097 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.58613657 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.52457096 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51023093 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 1.49818127 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.47736898 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40964879 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.39680128 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38053767 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.37586671 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37409327 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36279318 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35396410 |
| 35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.35160370 |
| 36 | RNA transport_Homo sapiens_hsa03013 | 1.34936246 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33533858 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32292065 |
| 39 | Spliceosome_Homo sapiens_hsa03040 | 1.30417958 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.29310670 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.26701338 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.25339173 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25131773 |
| 44 | Homologous recombination_Homo sapiens_hsa03440 | 1.23769497 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21471283 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16182882 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.16061246 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.14938965 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13980839 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 1.13922405 |
| 51 | Cell cycle_Homo sapiens_hsa04110 | 1.12283782 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11691285 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10542797 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08819679 |
| 55 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08479312 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06439694 |
| 57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05275096 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04893619 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04390509 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01348828 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.99327169 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99151328 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.96852900 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93636826 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93401875 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93356640 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 0.93203392 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93144580 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88283789 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87650626 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87315793 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84837903 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.84342210 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83095486 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82229287 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.81222658 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.79848461 |
| 78 | Protein export_Homo sapiens_hsa03060 | 0.78561102 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77341427 |
| 80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74841067 |
| 81 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74436393 |
| 82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73843255 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73176030 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73075739 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72957215 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72929597 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72458762 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72156100 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69592931 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68423415 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68103520 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67501707 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67320541 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66027043 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65270854 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62943462 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.62793395 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62611093 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.61317366 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60130348 |
| 101 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58882955 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54611637 |
| 103 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54102402 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.53561699 |
| 105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51150852 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51039973 |
| 107 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50951960 |
| 108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50009185 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47386891 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45746942 |
| 111 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45563474 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44324297 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41558765 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41204578 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41202141 |
| 116 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39922802 |
| 117 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39784997 |
| 118 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.39399984 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39105830 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37100987 |
| 121 | Insulin secretion_Homo sapiens_hsa04911 | 0.37090673 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37077553 |
| 123 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36128766 |
| 124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30516580 |
| 125 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28352596 |

